s6y

China SXT Pharmaceuticals, Inc.

Ticker
SXTC
CIK
1723980
Industry
Pharmaceutical Preparations

Financials 3

  1. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Mar 31, 2024
  2. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Mar 31, 2021
  3. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Mar 31, 2019

Ownership 24

  1. 3 Initial statement of beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities
  8. SC 13G/A Major Shareholders
  9. SC 13G/A Major Shareholders
  10. SC 13G/A Major Shareholders

All 24 ownership filings

Prospectus 21

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  5. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  6. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  7. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  8. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. 424B7 Prospectus filed pursuant to Rule 424(b)(7)

All 21 prospectus filings

Other 121

  1. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  2. SCHEDULE 13G
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  6. EFFECT Notice of Effectiveness
  7. F-3/A Registration statement for specified transactions by certain foreign private issuers
  8. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  9. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  10. F-3 Registration statement for specified transactions by certain foreign private issuers

All 121 other filings